Demands for 'off-licence' access to trastuzumab (Herceptin): content analysis of UK newspaper articles.
about
Drugs, cancer and end-of-life care: a case study of pharmaceuticalization?Exploring the perspectives and preferences for HTA across German healthcare stakeholders using a multi-criteria assessment of a pulmonary heart sensor as a case study.The media and access issues: content analysis of Canadian newspaper coverage of health policy decisions.Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study.Depoliticisation, Resilience and the Herceptin Post-Code Lottery Crisis: Holding Back the Tide.
P2860
Demands for 'off-licence' access to trastuzumab (Herceptin): content analysis of UK newspaper articles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Demands for 'off-licence' acce ...... ysis of UK newspaper articles.
@en
Demands for 'off-licence' access to trastuzumab
@nl
type
label
Demands for 'off-licence' acce ...... ysis of UK newspaper articles.
@en
Demands for 'off-licence' access to trastuzumab
@nl
prefLabel
Demands for 'off-licence' acce ...... ysis of UK newspaper articles.
@en
Demands for 'off-licence' access to trastuzumab
@nl
P2860
P1433
P1476
Demands for 'off-licence' acce ...... ysis of UK newspaper articles.
@en
P2093
Allan J Wailoo
Paul Sutcliffe
P2860
P356
10.1111/J.1369-7625.2010.00617.X
P50
P577
2011-03-01T00:00:00Z